
La Jolla Pharmaceutical Company LJPC
La Jolla Pharmaceutical Company Depreciation & Amortization | LJPC
Annual Depreciation & Amortization La Jolla Pharmaceutical Company
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111 K | 2.19 M | 4.55 M | 4.4 M | 1.27 M | 730 K | 347 K | 17 K | 5 K | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.55 M | 5 K | 1.51 M |
Quarterly Depreciation & Amortization La Jolla Pharmaceutical Company
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 48 K | 25 K | - | 84 K | 56 K | 29 K | - | 2.16 M | 1.8 M | 1.06 M | - | 3.41 M | 2.26 M | 1.13 M | - | 3.24 M | 2.09 M | 992 K | - | 899 K | 581 K | 281 K | - | 510 K | 310 K | 142 K | - | 114 K | 84 K | 11 K | - | 10 K | 5 K | 2 K | - | 3 K | 1 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.41 M | 1 K | 762 K |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Ayala Pharmaceuticals
AYLA
|
162 K | - | - | $ 7.46 M | ||
|
Revolution Medicines
RVMD
|
7.78 M | $ 207.32 | 0.24 % | $ 39.4 B | ||
|
Rhythm Pharmaceuticals
RYTM
|
500 K | $ 101.8 | 0.08 % | $ 6.62 B | ||
|
Rezolute
RZLT
|
31 K | $ 4.4 | 0.88 % | $ 334 M | ||
|
Sana Biotechnology
SANA
|
12.8 M | $ 3.45 | 0.77 % | $ 874 M | ||
|
Seer
SEER
|
5.12 M | $ 1.95 | 0.26 % | $ 108 M | ||
|
Precigen
PGEN
|
3.2 M | $ 6.87 | 0.14 % | $ 2.15 B | ||
|
SIGA Technologies
SIGA
|
563 K | $ 3.2 | 1.86 % | $ 229 M | ||
|
Syndax Pharmaceuticals
SNDX
|
6 M | $ 19.94 | 0.05 % | $ 1.73 B | ||
|
Soligenix
SNGX
|
62.4 K | $ 0.38 | 1.18 % | $ 1.97 M | ||
|
Spruce Biosciences
SPRB
|
21 K | $ 59.09 | 2.0 % | $ 45.3 M | ||
|
Sarepta Therapeutics
SRPT
|
44.5 M | $ 20.94 | 0.04 % | $ 2.1 B | ||
|
Stoke Therapeutics
STOK
|
1.77 M | $ 30.05 | 0.81 % | $ 1.78 B | ||
|
Sutro Biopharma
STRO
|
7.32 M | $ 19.1 | 0.34 % | $ 162 M | ||
|
Shattuck Labs
STTK
|
3.7 M | $ 6.5 | 0.29 % | $ 452 M | ||
|
Supernus Pharmaceuticals
SUPN
|
91.6 M | $ 42.43 | 0.23 % | $ 2.4 B | ||
|
Savara
SVRA
|
87 K | $ 5.53 | 2.98 % | $ 1.23 B | ||
|
China SXT Pharmaceuticals
SXTC
|
73.7 K | $ 2.24 | 0.45 % | $ 1.52 M | ||
|
Bio-Techne Corporation
TECH
|
97.4 M | $ 72.31 | 0.01 % | $ 11.3 B | ||
|
Tenax Therapeutics
TENX
|
8 K | $ 1.98 | 2.06 % | $ 77.7 M | ||
|
Teva Pharmaceutical Industries Limited
TEVA
|
1 B | $ 36.76 | 1.21 % | $ 42.1 B | ||
|
TG Therapeutics
TGTX
|
59 K | $ 55.74 | 0.58 % | $ 8.04 B | ||
|
Trevi Therapeutics
TRVI
|
144 K | $ 16.82 | 1.17 % | $ 2.27 B | ||
|
Taysha Gene Therapies
TSHA
|
1.14 M | $ 5.48 | 0.54 % | $ 1.75 B | ||
|
Sol-Gel Technologies Ltd.
SLGL
|
109 K | $ 69.37 | 0.35 % | $ 193 M | ||
|
UroGen Pharma Ltd.
URGN
|
307 K | $ 43.82 | 0.02 % | $ 2.11 B | ||
|
United Therapeutics Corporation
UTHR
|
85.6 M | $ 497.97 | 2.12 % | $ 22.1 B | ||
|
Spero Therapeutics
SPRO
|
2 K | $ 1.19 | 0.41 % | $ 66.7 M | ||
|
Scholar Rock Holding Corporation
SRRK
|
1.66 M | $ 57.42 | 3.78 % | $ 6.59 B | ||
|
Jounce Therapeutics
JNCE
|
2.09 M | - | - | $ 98.4 M | ||
|
NextCure
NXTC
|
2.2 M | $ 8.42 | 7.67 % | $ 23.9 M | ||
|
Verrica Pharmaceuticals
VRCA
|
133 K | $ 5.26 | 0.75 % | $ 56 M | ||
|
Viridian Therapeutics
VRDN
|
460 K | $ 23.17 | 1.09 % | $ 2.36 B | ||
|
Zosano Pharma Corporation
ZSAN
|
1.75 M | - | 7.23 % | $ 2.72 M | ||
|
Vertex Pharmaceuticals Incorporated
VRTX
|
210 M | $ 528.9 | 0.22 % | $ 135 B | ||
|
Verastem
VSTM
|
30 K | $ 8.08 | 0.55 % | $ 560 M | ||
|
vTv Therapeutics
VTVT
|
16 K | $ 32.79 | 0.03 % | $ 130 M | ||
|
Voyager Therapeutics
VYGR
|
4.06 M | $ 3.4 | 3.85 % | $ 200 M | ||
|
Aravive
ARAV
|
886 K | - | -13.39 % | $ 1.45 M | ||
|
Wave Life Sciences Ltd.
WVE
|
3.44 M | $ 4.91 | 1.03 % | $ 828 M | ||
|
Tonix Pharmaceuticals Holding Corp.
TNXP
|
1.92 M | $ 13.16 | 0.15 % | $ 112 M | ||
|
Xenetic Biosciences
XBIO
|
1 K | $ 4.28 | 0.86 % | $ 7.28 M | ||
|
XBiotech
XBIT
|
1.69 M | $ 2.18 | 0.23 % | $ 66.5 M | ||
|
Exicure
XCUR
|
242 K | $ 1.41 | 12.8 % | $ 8.88 M | ||
|
Xenon Pharmaceuticals
XENE
|
2.54 M | $ 59.55 | 0.18 % | $ 4.72 B | ||
|
Xeris Pharmaceuticals
XERS
|
1.31 M | $ 8.48 | 0.12 % | $ 1.36 B |